Double-Blind, Placebo-Controlled Pilot Study on the Use of Platelet-Rich Plasma in Women With Female Androgenetic Alopecia
2016; Lippincott Williams & Wilkins; Volume: 42; Issue: 11 Linguagem: Inglês
10.1097/dss.0000000000000883
ISSN1524-4725
AutoresCarlos J. Puig, Robert J. Reese, Michelle Peters,
Tópico(s)Genital Health and Disease
ResumoPlatelet-rich plasma (PRP) has been suggested as a therapeutic intervention for female androgenetic alopecia.To perform a pilot study on the effect of PRP scalp injections in women with female androgenetic alopecia.This double-blind, multicenter, placebo-controlled study compared the effect of PRP with that of saline placebo as scalp injection. The endpoints were hair count and hair mass index (HMI), along with patient-opinion survey responses. Platelet-rich plasma was manufactured from patients' blood using the Angel PRP system.Hair mass index or hair count did not statistically significantly differ between the study and placebo groups. However, 13.3% of the treatment subjects (vs 0% of the placebo subjects) experienced substantial improvement in hair loss, rate of hair loss, hair thickness, and ease of managing/styling hair, and 26.7% (vs 18.2% of the placebo group) reported that their hair felt coarser or heavier after the treatment.Platelet-rich plasma failed to demonstrate any statistically significant improvement in HMI or hair count in women with congenital female pattern hair loss. The patient survey results suggest a therapeutic advantage of PRP as perceived by patients but not according to hair count or HMI.
Referência(s)